Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -91866.00% is 942% below its 5-year average of -8818.67%, near the low end of its 5-year range (-91866.00%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-91866.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-6962.76%
NET PROFIT MARGIN AVG 5Y
-8818.67%
NET PROFIT MARGIN AVG 10Y
-2787.90%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-1219.39%
CURRENT VS 5Y AVG
-941.72%
CURRENT VS 10Y AVG
-3195.16%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-26247328.57%
vs the sector median at left
INmune Bio, Inc.
Market Cap
$49.71M
Net Profit Margin
-91866.00%
TTM Avg
0.00%
3Y Avg
-6962.76%
5Y Avg
-8818.67%
Market Cap
$49.45M
Net Profit Margin
-20059.90%
TTM Avg
-12303.49%
3Y Avg
-9625.39%
5Y Avg
-8201.08%
Market Cap
$49.25M
Net Profit Margin
-11.51%
TTM Avg
-20.89%
3Y Avg
-14.48%
5Y Avg
-10.80%
Market Cap
$50.27M
Net Profit Margin
-11304.83%
TTM Avg
-9549.74%
3Y Avg
-8821.76%
5Y Avg
-6347.57%
Market Cap
$48.89M
Net Profit Margin
-88.45%
TTM Avg
-6.09%
3Y Avg
11.06%
5Y Avg
-1.98%
Market Cap
$48.77M
Net Profit Margin
-51.53%
TTM Avg
-51.48%
3Y Avg
-72.44%
5Y Avg
-93.46%
Market Cap
$48.76M
Net Profit Margin
-4722.25%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$48.53M
Net Profit Margin
-128.69%
TTM Avg
-13664.85%
3Y Avg
-30726.86%
5Y Avg
-811138.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $49.71M | -91866.00% | 0.00% | -6962.76% | -8818.67% |
| Clene Inc. (CLNN)vs › | $49.45M | -20059.90% | -12303.49% | -9625.39% | -8201.08% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -11.51% | -20.89% | -14.48% | -10.80% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -11304.83% | -9549.74% | -8821.76% | -6347.57% |
| biote Corp. (BTMD)vs › | $50.28M | 3.19% | 7.83% | 4.22% | 10.88% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -88.45% | -6.09% | 11.06% | -1.98% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | -51.53% | -51.48% | -72.44% | -93.46% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -4722.25% | 0.00% | 0.00% | 0.00% |
| Apollomics, Inc. (APLM)vs › | $48.53M | -128.69% | -13664.85% | -30726.86% | -811138.03% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-61738.0%
Net Profit Margin
-91866.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -19478.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -78750.00% |
| 2023-12-31 | -30028.57% |
| 2023-09-30 | -19913.95% |
| 2023-06-30 | -14132.61% |
| 2023-03-31 | -17200.00% |
| 2022-12-31 | -6013.40% |
| 2022-09-30 | -7882.65% |
| 2022-06-30 | -42737.50% |
| 2022-03-31 | -4234.97% |
| 2021-12-31 | -5933.13% |
| 2021-09-30 | -67557.14% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | -113900.00% |
| 2020-12-31 | -29127.27% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
